Open Access
| Issue |
Med Sci (Paris)
Volume 42, Number 2, Février 2026
|
|
|---|---|---|
| Page(s) | 137 - 140 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2026009 | |
| Published online | 24 February 2026 | |
- Hanahan D. Hallmarks of cancer: New dimensions. Cancer Discov 2022 ; 12 : 31–46. [CrossRef] [PubMed] [Google Scholar]
- Smith ZD, Hetzel S, Meissner A. DNA methylation in mammalian development and disease. Nat Rev Genet 2025 ; 26 : 7–30. [Google Scholar]
- Nishiyama A, Nakanishi M. Navigating the DNA methylation landscape of cancer. Trends Genet 2021 ; 37 : 1012–27. [Google Scholar]
- Gorse M, Bianchi C, Proudhon C. Épigénétique et cancer : la méthylation dans tous ses états. Med Sci (Paris) 2024 ; 40 : 925–34. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Petryk N, Bultmann S, Bartke T, et al. Staying true to yourself: mechanisms of DNA methylation maintenance in mammals. Nucleic Acids Res 2021 ; 49 : 3020–32. [Google Scholar]
- Ferry L, Fournier A, Tsusaka T, et al. Methylation of DNA ligase 1 by G9a/GLP recruits UHRF1 to replicating DNA and regulates DNA methylation. Mol Cell 2017 ; 67 : 550–65.e5. [Google Scholar]
- Mudbhary R, Hoshida Y, Chernyavskaya Y, et al. UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma. Cancer Cell 2014 ; 25 : 196–209. [Google Scholar]
- Kong X, Chen J, Xie W, et al. Defining UHRF1 domains that support maintenance of human colon cancer DNA methylation and oncogenic properties. Cancer Cell 2019 ; 35 : 633–48.e7. [Google Scholar]
- Stomper J, Rotondo JC, Greve G, et al. Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies. Leukemia 2021 ; 35 : 1873–89. [Google Scholar]
- Yamaguchi K, Chen X, Rodgers B, et al. Non-canonical functions of UHRF1 maintain DNA methylation homeostasis in cancer cells. Nat Commun 2024 ; 15 : 2960. [Google Scholar]
- Chen X, Yamaguchi K, Rodgers B, et al. DNA methylation protects cancer cells against senescence. Nat Commun 2025 ; 16 : 5901. [Google Scholar]
- Gorgoulis V, Adams PD, Alimonti A, et al. Cellular senescence: Defining a path forward. Cell 2019 ; 179 : 813–27. [CrossRef] [PubMed] [Google Scholar]
- Wang L, Lankhorst L, Bernards R. Exploiting senescence for the treatment of cancer. Nat Rev Cancer 2022 ; 22 : 340–55. [Google Scholar]
- Pappalardi MB, Keenan K, Cockerill M, et al. Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia. Nat Cancer 2021 ; 2 : 1002–17. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.